Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly oral mifepristone 50 mg for contraception
2020-002355-38Phase 3
- Sponsor
- Women on Web
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mifepristone in contraception, sponsored by Women on Web. Primary endpoints: Contraceptive efficacy and Safety.
02
Drugs
mifepristone
03
Conditions
contraception
Beyond the preview
Go deeper on 2020-002355-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002355-38.